Specifications include, but are not limited to: The State of Wisconsin, Department of Health Services (“DHS”), is engaged in efforts to support communities around Wisconsin by reducing the impact of COVID-19 on individuals, businesses, and the healthcare system. The Food and Drug Administration ("FDA") has granted Emergency Use Authorization ("EUA") to several therapeutic medications with the potential to significantly reduce hospitalizations and deaths. In clinical trials for the drug Paxlovid, patients taking the medication had 88% lower chance of hospitalization or death compared to no treatment. Subsequent studies have shown Paxlovid is highly effective. If prescribed at scale, Paxlovid has the potential to avert costly hospitalizations for COVID-19, reduce strain on the healthcare system, and save lives. Molnupiravir, another COVID-19 drug distributed by the federal government, has also been shown to be effective in reducing the risk of severe illness. Despite the effectiveness of COVID-19 medications, at least (3) three factors prevent their widespread use: (1) provider aversion to prescribe because the medications are complex and require time-consuming consultations; (2) centralized prescribing services developed by health systems, which fail to scale during times of surge; and (3) uninsured or underinsured patients who cannot readily access these medications after a COVID-19 diagnosis. Telehealth services address these issues by connecting any patient, regardless of insurance status, with an experienced clinician who can safely prescribe one of these therapeutics. Telehealth services can also rapidly scale during times of surge and quickly reach large numbers of patients, including patients who are unable to leave their homes or places of care. DHS is seeking services from vendors with the necessary skills and resources to provide a telehealth solution for Wisconsin residents. DHS envisions this as a multi-channel solution via web, app, or phone whereby residents are pre-screened for eligibility, connected to a licensed clinician, and prescribed treatment if medically appropriate.